Design, synthesis, in silico pharmacokinetics prediction and biological evaluation of 1,4-dihydroindeno[1,2-c]pyrazole chalcone as EGFR /Akt pathway inhibitors

Global cancer statistics, 2012

Lindsey A. Torre, Freddie Bray, Rebecca L. Siegel et al. · CA A Cancer Journal for Clinicians · 2015 · 27.2K citations · Full text

SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules

Antoine Daina, Olivier Michielin, Vincent Zoete · Scientific Reports · 2017 · 15.8K citations · Full text

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy et al. · Advanced Drug Delivery Reviews · 1997 · 11K citations

Development Settings, Pharmaceutical Science, Drug Target +8

Global cancer transitions according to the Human Development Index (2008–2030): a population-based study

Freddie Bray, Ahmedin Jemal, Nathan Grey et al. · The Lancet Oncology · 2012 · 2.2K citations

Population-based Study, Cancer Risk, Cancer Epidemiology +12

Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression

Jiyong Liang, Joyce M. Slingerland · Cell Cycle · 2003 · 880 citations

Cell Death, G2/m Transition, Cell Cycle +18